Moncef Slaoui

Moncef Slaoui served as Chief Advisor for the US government’s COVID-19 vaccine development effort, Operation Warp Speed (OPWASP).

Slaoui previously spent nearly 30 years at GlaxoSmithKline (GSK), most recently as Chairman of Global Vaccines, and sat on GSK’s board from 2006 until his retirement.

He also was on Moderna’s Board of Directors between 2017 and 2020 the start of Operation Warp Speed in 2020.

ixLayer Platform - Population Health Management in the Covid-19 Era


ixlayer is the healthcare platform for user-friendly at-home and on-site health testing programs at scale. ixlayer’s solutions enable health plans, government entities, telehealth providers, retailers, health systems, pharmaceutical and biotech companies to deploy configurable programs quickly and easily.

ixlayer offers thousands of health testing options for decentralized clinical trials, closing care gaps, and direct to consumer solutions, all under today's most trusted brands.


You Might Also Like

Be the first to know!

Sign up to our newsletter to receive the latest industry news, and trends.